PG vs RCUS · P/E 25, rev $84.28B vs rev $258.0M
Procter & Gamble Company (PG) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the PG and RCUS stock pages for the full models.
Not investment advice.